Differentiation of biliary atresia using a rapid point-of-care matrix metalloproteinase-7 assay: A multicenter diagnostic study
Abstract
BACKGROUND: Delayed diagnosis and surgery are the main causes of poor prognosis in biliary atresia (BA). This delay is frequently attributed to the complexity of current outpatient evaluation methods. While serum MMP-7 analysis via currently available methods, such as ELISA, offers high diagnostic accuracy, its utility in outpatient settings is often limited by turnaround time. To address this challenge, we developed and evaluated the MMP-7 Quick Test for accurately differentiating BA. METHODS: This multicenter prospective diagnostic study was conducted between November 2021 and December 2024 at the pediatric surgery outpatient departments of 5 tertiary centers. A total of 423 patients aged
Fields of Study & Subjects
Pediatric Hepatobiliary Diseases and Treatments
Gallbladder and Bile Duct Disorders
Pancreatitis Pathology and Treatment
Publication details
- Journal / source
- Hepatology Communications
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 10
- Issue
- 5
- Publication date
- 24 April 2026
- Language
- EN